Verifying…
Home / Registered in Nigeria / Bentarpen Injection

Bentarpen Injection

NAFDAC Reg. No. A4-9168 · Drug

Registered with NAFDAC. Registration activeAs of 29 October 2026 · synced automatically from official sources.
Product
Bentarpen Injection
NAFDAC number
A4-9168
Active ingredient
Benzathine benzylpenicillin
Strength
2,400,000 IU
Form
Powder for injection
Pack size
1 x 50's (in vials)
Manufacturer
Not listed
Applicant (holder)
Sterling Drugs Limited
Approved
24 Jun 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
23 Jun 2026
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Benzathine benzylpenicillin: uses, dosage and brands worldwide

What we found

  • Bentarpen Injection is on the NAFDAC register with an active registration (A4-9168). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Bentarpen Injection

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling. WARNING NOT FOR INTRAVENOUS USE. …
Who it is for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin L-A and other antibacterial drugs, Bicillin L-A should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. …

How to take it and how often
  • Streptococcal (Group A) Upper Respiratory Infections (for example, pharyngitis)
  • Adults—a single injection of 1,200,000 units; older pediatric patients—a single injection of 900,000 units; infants and pediatric patients under 60 lbs.—300,000 to 600,000 units
  • Syphilis Primary, secondary, and latent—2,400,000 units (1 dose)
  • Late (tertiary and neurosyphilis)—2,400,000 units at 7-day intervals for three doses
  • Congenital—under 2 years of age: 50,000 units/kg/body weight; ages 2 to 12 years: adjust dosage based on adult dosage schedule
  • Yaws, Bejel, and Pinta —1,200,000 units (1 injection)
  • Prophylaxis —for rheumatic fever and glomerulonephritis
  • Following an acute attack, penicillin G benzathine (parenteral) may be given in doses of 1,200,000 units once a month or 600,000 units every 2 weeks
  • METHOD OF ADMINISTRATION BICILLIN L-A IS INTENDED FOR INTRAMUSCULAR INJECTION ONLY
  • DO NOT INJECT INTO OR NEAR AN ARTERY OR NERVE, OR INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. (SEE WARNINGS SECTION.) Administer by DEEP INTRAMUSCULAR INJECTION in the upper, outer quadrant of the buttock (dorsogluteal) or the ventrogluteal site
  • In neonates, infants and small children, the midlateral aspect of the thigh may be preferable
  • Administration in the anterolateral thigh is not recommended due to the adverse effects observed (see WARNINGS section), and vascularity of this region
  • When doses are repeated, vary the injection site
  • Because of the high concentration of suspended material in this product, the needle may be blocked if the injection is not made at a slow, steady rate. …
Children

(See INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION sections.)

Older adults

Clinical studies of penicillin G benzathine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. …

While you are taking it
  • Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued
  • Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic
  • If this occurs, patients should contact their physician as soon as possible
  • Patients should be counseled that antibacterial drugs including Bicillin L-A should only be used to treat bacterial infections
  • They do not treat viral infections (e.g., the common cold). …
Talk to a doctor first if

A history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

Medicines it may not mix with

Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. Concurrent administration of penicillin and probenecid increases and prolongs serum penicillin levels by decreasing the apparent volume of distribution and slowing the rate of excretion by competitively inhibiting renal tubular secretion of penicillin.

Warnings

WARNING NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling. Penicillin G benzathine should only be prescribed for the indications listed in this insert. Anaphylaxis SERIOUS AND OCCASIONALLY FATAL HYPERSENSITIVITY (ANAPHYLACTIC) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. …

Possible side effects

As with other penicillins, untoward reactions of the sensitivity phenomena are likely to occur, particularly in individuals who have previously demonstrated hypersensitivity to penicillins or in those with a history of allergy, asthma, hay fever, or urticaria. As with other treatments for syphilis, the Jarisch-Herxheimer reaction has been reported. The following adverse reactions have been reported with Bicillin L-A during post-marketing experience: Skin and Appendages: Stevens-Johnson syndrome (SJS) and drug reaction with eosinophilia and systemic symptoms (DRESS). …

Pregnancy and breastfeeding

Pregnancy Teratogenic effects Pregnancy Reproduction studies performed in the mouse, rat, and rabbit have revealed no evidence of impaired fertility or harm to the fetus due to penicillin G. Human experience with the penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus. …

If you take too much

Penicillin in overdosage has the potential to cause neuromuscular hyperirritability or convulsive seizures.

How to store it

Store in a refrigerator, 2° to 8°C (36° to 46°F). Keep from freezing.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-07-21.

Label for benzathine benzylpenicillin, the active ingredient registered with NAFDAC.

Check your pack of Bentarpen Injection

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Bentarpen Injection

What is in Bentarpen Injection?

Bentarpen Injection contains Benzathine benzylpenicillin (2,400,000 IU), as powder for injection, according to its NAFDAC registration record.

Is Bentarpen Injection registered with NAFDAC?

Yes. Bentarpen Injection is listed on the NAFDAC register under registration number A4-9168, and its registration is active as of 29 October 2026.

Has Bentarpen Injection been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Bentarpen Injection in our automatically synced alert list.

How can I check that my pack of Bentarpen Injection is genuine?

Run a free authenticity scan with the NAFDAC number A4-9168, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Bentarpen Injection?

Follow your prescription or the leaflet in your pack. The official label says: Streptococcal (Group A) Upper Respiratory Infections (for example, pharyngitis) Adults—a single injection of 1,200,000 units; older pediatric patients—a single injection of 900,000 units; infants and pediatric patients under 60 lbs.—300,000 to 600,000 units. Syphilis Primary, secondary, and latent—2,400,000 units (1 dose). Late (tertiary and neurosyphilis)—2,400,000 units at 7-…

What is Bentarpen Injection used for?

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin L-A and other antibacterial drugs, Bicillin L-A should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the (Summarised from the official U.S. FDA label for benzathine benzylpenicillin. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Bentarpen Injection? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.